|
| 36791345 | Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 37599093 | Quality of life after surgery for lower grade gliomas. | Cancer | 2023 |
| 37585633 | Targeting IDH in Low-Grade Glioma. | N Engl J Med | 2023 |
| 37329568 | Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas. | Neuro Oncol | 2023 |
| 36881002 | Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma. | Cancer Immunol Res | 2023 |
| 36689332 | GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data. | Neuro Oncol | 2023 |
| 37046089 | Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagus. | Nature | 2023 |
| 36791345 | Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 37488293 | Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. | Nat Med | 2023 |
| 37541751 | [<sup>18</sup>F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial. | BMJ Open | 2023 |
| 37488293 | Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. | Nat Med | 2023 |
| 37585633 | Targeting IDH in Low-Grade Glioma. | N Engl J Med | 2023 |
| 37541751 | [<sup>18</sup>F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial. | BMJ Open | 2023 |
| 37599093 | Quality of life after surgery for lower grade gliomas. | Cancer | 2023 |
| 37046089 | Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagus. | Nature | 2023 |
| 37329568 | Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas. | Neuro Oncol | 2023 |
| 36881002 | Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma. | Cancer Immunol Res | 2023 |
| 36689332 | GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data. | Neuro Oncol | 2023 |
| 34819316 | Live-Cell Imaging Shows Uneven Segregation of Extrachromosomal DNA Elements and Transcriptionally Active Extrachromosomal DNA Hubs in Cancer. | Cancer Discov | 2022 |
| 36355400 | Extrachromosomal DNA (ecDNA): an origin of tumor heterogeneity, genomic remodeling, and drug resistance. | Biochem Soc Trans | 2022 |
| 35953594 | Extrachromosomal DNA amplifications in cancer. | Nat Rev Genet | 2022 |
| 36202798 | Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAF<sup>V600E</sup> inhibition resistance in melanoma. | Cell Discov | 2022 |
| 36059614 | PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells. | Front Oncol | 2022 |
| 36122307 | Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma. | Cancer Discov | 2022 |
| 35316217 | Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression. | JCI Insight | 2022 |
| 35145903 | A Need for More Molecular Profiling in Brain Metastases. | Front Oncol | 2022 |
| 34819316 | Live-Cell Imaging Shows Uneven Segregation of Extrachromosomal DNA Elements and Transcriptionally Active Extrachromosomal DNA Hubs in Cancer. | Cancer Discov | 2022 |
| 35177608 | Spatiotemporal dynamics of clonal selection and diversification in normal endometrial epithelium. | Nat Commun | 2022 |
| 36202798 | Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAF<sup>V600E</sup> inhibition resistance in melanoma. | Cell Discov | 2022 |
| 36355400 | Extrachromosomal DNA (ecDNA): an origin of tumor heterogeneity, genomic remodeling, and drug resistance. | Biochem Soc Trans | 2022 |
| 36059614 | PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells. | Front Oncol | 2022 |
| 35953594 | Extrachromosomal DNA amplifications in cancer. | Nat Rev Genet | 2022 |
| 36122307 | Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma. | Cancer Discov | 2022 |
| 35316217 | Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression. | JCI Insight | 2022 |
| 35177608 | Spatiotemporal dynamics of clonal selection and diversification in normal endometrial epithelium. | Nat Commun | 2022 |
| 35145903 | A Need for More Molecular Profiling in Brain Metastases. | Front Oncol | 2022 |
| 33441554 | Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy. | Nat Commun | 2021 |
| 37185327 | LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study. | BMJ Open | 2021 |
| 34049406 | Spatial concordance of DNA methylation classification in diffuse glioma. | Neuro Oncol | 2021 |
| 34045764 | Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancer. | Nat Genet | 2021 |
| 33836152 | Oncogenic extrachromosomal DNA functions as mobile enhancers to globally amplify chromosomal transcription. | Cancer Cell | 2021 |
| 34139018 | Serum cell-free DNA epigenetic biomarkers aid glioma diagnostics and monitoring. | Neuro Oncol | 2021 |
| 33441554 | Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy. | Nat Commun | 2021 |
| 33762019 | Perspective of mesenchymal transformation in glioblastoma. | Acta Neuropathol Commun | 2021 |
| 34244484 | Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine. | Nat Commun | 2021 |
| 33434495 | A modular master regulator landscape controls cancer transcriptional identity. | Cell | 2021 |
| 34615987 | HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions. | Leukemia | 2021 |
| 34594038 | Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response. | Nat Genet | 2021 |
| 37185327 | LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study. | BMJ Open | 2021 |
| 33762019 | Perspective of mesenchymal transformation in glioblastoma. | Acta Neuropathol Commun | 2021 |